HY-16474-10mg
|
MedChemexpress LLC
|
Relugolix [CAS 737789-87-6]
|
|
Cancer-programmed cell death
|
|
HY-16474-100mg
|
MedChemexpress LLC
|
Relugolix [CAS 737789-87-6]
|
|
Cancer-programmed cell death
|
|
HY-16474-5mg
|
MedChemexpress LLC
|
Relugolix [CAS 737789-87-6]
|
|
Cancer-programmed cell death
|
|
HY-16474-50mg
|
MedChemexpress LLC
|
Relugolix [CAS 737789-87-6]
|
|
Cancer-programmed cell death
|
|
HY-16474-1mL
|
MedChemexpress LLC
|
Relugolix [CAS 737789-87-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-19306-1mg
|
MedChemexpress LLC
|
SB-267268 [CAS 205678-26-8]
|
|
Cancer-programmed cell death
|
|
HY-19306-10mg
|
MedChemexpress LLC
|
SB-267268 [CAS 205678-26-8]
|
|
Cancer-programmed cell death
|
|
HY-19306-100mg
|
MedChemexpress LLC
|
SB-267268 [CAS 205678-26-8]
|
|
Cancer-programmed cell death
|
|
HY-19306-25mg
|
MedChemexpress LLC
|
SB-267268 [CAS 205678-26-8]
|
|
Cancer-programmed cell death
|
|
HY-19306-5mg
|
MedChemexpress LLC
|
SB-267268 [CAS 205678-26-8]
|
|
Cancer-programmed cell death
|
|
HY-19306-50mg
|
MedChemexpress LLC
|
SB-267268 [CAS 205678-26-8]
|
|
Cancer-programmed cell death
|
|
HY-16209-1mg
|
MedChemexpress LLC
|
Forodesine (hydrochloride) [CAS 284490-13-7]
|
|
Cancer-programmed cell death
|
|
HY-16209-10mg
|
MedChemexpress LLC
|
Forodesine (hydrochloride) [CAS 284490-13-7]
|
|
Cancer-programmed cell death
|
|
HY-16209-25mg
|
MedChemexpress LLC
|
Forodesine (hydrochloride) [CAS 284490-13-7]
|
|
Cancer-programmed cell death
|
|
HY-16209-5mg
|
MedChemexpress LLC
|
Forodesine (hydrochloride) [CAS 284490-13-7]
|
|
Cancer-programmed cell death
|
|
HY-16209-50mg
|
MedChemexpress LLC
|
Forodesine (hydrochloride) [CAS 284490-13-7]
|
|
Cancer-programmed cell death
|
|
HY-16210-1mg
|
MedChemexpress LLC
|
Forodesine [CAS 209799-67-7]
|
|
Cancer-programmed cell death
|
|
HY-16210-10mg
|
MedChemexpress LLC
|
Forodesine [CAS 209799-67-7]
|
|
Cancer-programmed cell death
|
|
HY-16210-25mg
|
MedChemexpress LLC
|
Forodesine [CAS 209799-67-7]
|
|
Cancer-programmed cell death
|
|
HY-16210-5mg
|
MedChemexpress LLC
|
Forodesine [CAS 209799-67-7]
|
|
Cancer-programmed cell death
|
|
HY-16210-50mg
|
MedChemexpress LLC
|
Forodesine [CAS 209799-67-7]
|
|
Cancer-programmed cell death
|
|
HY-153360-1mg
|
MedChemexpress LLC
|
MC-GGFG-AM-(10Me-11F-Camptothecin) [CAS 2873460-70-7]
|
|
Cancer-programmed cell death
|
|
HY-153360-10mg
|
MedChemexpress LLC
|
MC-GGFG-AM-(10Me-11F-Camptothecin) [CAS 2873460-70-7]
|
|
Cancer-programmed cell death
|
|
HY-153360-5mg
|
MedChemexpress LLC
|
MC-GGFG-AM-(10Me-11F-Camptothecin) [CAS 2873460-70-7]
|
|
Cancer-programmed cell death
|
|